NCT00741689View on ClinicalTrials.gov

A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

AZD1656

Dose escalation of oral single doses of AZD1656 to achieve maximal tolerated dose

Trial Locations (1)

Unknown

Research Site, Glendale

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY